תאריך: 01/11/2012
Patients with b-thalassemia major (TM) and other refractory anemias requiring regular blood transfusions accumulate iron that damages the liver, endocrine system, and most importantly the heart. The prognosis in TM has improved remarkably over the past 10 years.
BLOOD, 1 NOVEMBER 2012 | VOLUME 120, NUMBER 18
